by The Bacillus Coagulans bacteria produces enzymes like proteases, amylases and lipases that help in the digestion of food. Supplying Bacillus Coagulans as a probiotic supplement promotes a healthy gastrointestinal tract and aids digestion. With rising cases of irritable bowel syndrome, dyspepsia and other digestive disorders, people are increasingly opting for Bacillus Coagulans supplements to ensure smooth digestive processes.
The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the Bacillus Coagulans market is the increasing demand for vegetarian and vegan probiotic supplements. With growing awareness about the health impacts of non-vegetarian food and a general shift towards plant-based diets, people are looking for vegetarian and vegan-friendly probiotic supplements. Bacillus Coagulans is suitable for vegetarians and vegans as it is not an animal-derived ingredient. Most commercial Bacillus Coagulans supplements are also free from common food allergens like dairy, soy, gluten etc. Manufacturers are developing innovative vegan probiotic formulations containing Bacillus Coagulans as the proprietary strain to cater to this rising consumer segment. This is expected to significantly drive the growth of the Bacillus Coagulans market during the forecast period.
Porter’s Analysis
Threat of new entrants: Low barriers to entry in the probiotics industry such as raw material and distribution channel availability pose moderate threat of new entrants.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and undifferentiated products. However, health benefits offered by Bacillus Coagulans provides some product differentiation.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to availability of alternatives and undifferentiated nature of raw materials.
Threat of new substitutes: Moderate threat from new probiotic substitutes and prebiotics offering similar health benefits as Bacillus Coagulans.
Competitive rivalry: Significant competition exists among existing players to gain market share and differentiate products based on strains and health benefits.
Key Takeaways
The Global Bacillus Coagulans Market Size is expected to witness high growth. The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030.
North America is expected to dominate the Bacillus Coagulans market during the forecast period. Rising health awareness coupled with growing gut health trend in the region is supporting market growth.
Europe Bacillus Coagulans market is also anticipated to showcase notable growth owing to increasing adoption of probiotic supplements for various digestive disorders like IBS and IBD. Factors like growing aged population and focus on preventive healthcare further augment the regional market.
Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. Players are focusing on new product launches, collaborations and geographical expansion to gain competitive edge in the market.
